Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis

Pathology International

Volumn 52, Issue 3, 2002, Pages 214-223

  Shu, Yujing ^a   Hoshi, Sachi ^a   Tomari, Shinsuke ^a   Watanabe, Teruo ^a   Nagata, Michio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

smooth muscle actin; Adriamycin; Cell cycle; Kidney; Osteopontin; Phenotypic change; Proliferating cell nuclear antigen; Proteinuria; Rat; Tubulointerstitial injury

Indexed keywords

ACTIN; CELL NUCLEUS ANTIGEN; DOXORUBICIN; OSTEOPONTIN; THROMBOMODULIN; VIMENTIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTERSTITIAL NEPHRITIS; KIDNEY CELL; KIDNEY CORTEX; KIDNEY TUBULE; MALE; NEPHROSIS; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; WESTERN BLOTTING;

ACTINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL CYCLE; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOXORUBICIN; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; OSTEOPONTIN; PHENOTYPE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SIALOGLYCOPROTEINS; TIME FACTORS; VIMENTIN;

EID: 0036961960     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2002.01339.x     Document Type: Article

References (48)

1. el Nahas AM, Zoop SN, Evans DJ, Rees AJ. Chronic renal failure after nephrotoxic nephritis in rats: Contribution to progression. Kidney Int. 1987; 36: 173-180.
2. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G. Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int. 1986; 30: 488-496.
3. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 1992; 20: 1-17.
4. Bohle A, Grund KE, Mackensen S, Tolon M. Correlation between renal interstitium and level of serum creatinine: Morphometric investigations of biopsies in perimembranous glomerulonephritis. Virchows Arch. A 1977; 373: 15-22.
5. Bohle A, Mackenson-Haen S, von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am. J. Nephrol. 1987; 7: 421-433.
6. Bohle A, Wehrmann M, Bogenschutz O et al. The long-term prognosis of primary glomerulonephritis: A morphological and clinical analysis of 1747 cases. Pathol. Res. Pract. 1992;188: 908-924.
7. Striker GE, Schainuck LI, Cutler RE, Benditt EP. Structural-functional correlations in renal disease. Part 1: A method for assaying and classifying histopathologic changes in renal disease. Hum. Pathol. 1970;1: 615-630.
8. Schainuck LI, Striker GE, Culter RE, Benditt EP. Structural-functional correlations in renal disease. Part 11: The correlations. Hum. Pathol. 1970;1: 631-641.
9. Risdon RA, Sloper JAS, de Wardener H. Relations between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;2: 363-366.
10. Mackensen-Haen S, Bader R, Grund K, Bohle A. Correlation between renal cortical interstitial fibrosis, atrophy of proximal tubules and impairment of glomerular filtration rate. Clin. Nephrol. 1981;15: 167-171.
11. Eddy AA. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 1996;7: 2495-2508.
12. Tang WW, Ulich TR, Lacey DL et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 1996; 148: 1169-1180.
13. Harris KP, Burton C, Walls J. Proteinuria: A mediator of interstitial fibrosis? Contrib. Nephrol. 1996;118: 173-179.
14. Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am. J. Kidney Dis. 1996;27: 765-775.
15. Benigni A, Zoja C, Remuzzi G. Biology of disease: The renal toxicity of sustained glomerular protein traffic. Lab. Invest. 1995;73: 461-466.
16. 5 integrin. Kidney Int. 1996;50: 1310-1320.
17. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am. J. Pathol. 1989;135: 719-733.
18. Haverty TP, Kelly CJ, Hines WH et al. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 1988;107: 1359-1367.
19. Healy E, Brady HR. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr. Opin. Nephrol. Hypertens. 1998;7: 525-530.
20. Tamaki K, Okuda S, Miyazono K, Nakayama M, Fujishima M. Matrix-associated latent TGF-β with latent TGF-β binding protein in the progressive process in adriamycin-induced nephropathy. Lab. Invest. 1995;73: 81-89.
21. Healy E, Brady HR. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr. Opin. Nephrol. Hypertens. 1998;7: 525-530.
22. Bertani T, Poggi A, Pozzoni R et al. Adriamycin-induced nephrotic syndrome in rats. Sequence of pathologic events. Lab. Invest. 1982;46: 16-23.
23. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 1986;29: 502-510.
24. Nangaku M, Pippin J, Couser WG. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 1999; 10: 2323-2331.
25. Grone HJ, Weber K, Grone E et al. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am. J. Pathol. 1987;129: 1-8.
26. Eddy AA, McCulloch L, Liu E, Adams J. A relationship between proteinuria and acute tubulointerstitial nephrotic syndrome. Am. J. Pathol. 1991;138: 1111-1123.
27. Giachelli CM, Pichler R, Lombardi D et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 1994;45: 515-524.
28. Diamond JR, Kees-Folts D, Ricardo SD et al. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am. J. Pathol. 1995;146: 1455-1466.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1994;119: 493-501.
30. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int. 1995;48: 753-760.
31. Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. Am. J. Soc. Nephrol. 2000;11: 47-56.
32. Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor. I-kappaB. J. Biol. Chem. 2000; 275: 883-889.
33. Magil AB, Pichler RH, Johnson RJ. Osteopontin in chronic puromycin aminonucleoside nephrosis. J. Am. Soc. Nephrol. 1997;8: 1383-1390.
34. Yu XQ, Wu LL, Huang XR et al. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II. Kidney Int. 2000;58: 1469-1480.
35. Bertani T, Poggi A, Pozzoni R et al. Adriamycin-induced nephrotic syndrome in rats. Lab. Invest. 1982;46: 16-23.
36. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison withflow cytometric analysis. Am. J. Pathol. 1989;134: 733-739.
37. Hall PA, NcKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993;8: 203-207.
38. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992;21: 591-594.
39. Amore PD. Tissue repair: Cellular growth, fibrosis, and wound healing. In: Cotran RS, Kumar V, Collins T, eds. Pathologic Basis of Disease, 6th Edn. Philadelphia: WB Saunders, 1999; 90-92.
40. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin: A possible anchor of osteoclasts to bone. Proc. Natl Acad. Sci. USA 1990;87: 4473-4475.
41. Butler WT. Structural and functional domains of osteopontin. Ann. NY Acad. Sci. USA 1995;760: 6-11.
42. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271: 509-512.
43. 3 integrin-induced endothelial cell survival. J. Cell Biol. 1998;141: 1083-1093.
44. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC. Macrophages in renal injury. Kidney Int. 1994;45: S79-S82.
45. Diamond JR, Pesek-Diamond I. Sublethal x-irradiation during acute puromycin nephrosis prevents late renal injury: Role of macrophages. Am. J. Physiol. 1991;260: F779-F786.
46. Imasawa T, Nagasawa R, Utsunomiya Y et al. Bone marrow transplantation attenuates murine IgA nephropathy: Role of a stem cell disorder. Kidney Int. 1999;56: 1809-1817.
47. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulosclerosis. Am. J. Pathol. 1997; 151: 1231-1239.
48. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of post-glomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press. Res. 1996;19: 191-195.